Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
Does Orion Oyj (HLSE:ORNBV) Dividend Hike Clarify Its Oncology-Pivot Capital Allocation Strategy? [Yahoo! Finance]
Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Developments [Yahoo! Finance]
The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company's key persons [Yahoo! Finance]
Notice to the Annual General Meeting of Orion Corporation [Yahoo! Finance]